,
Erik Vollebregt
On Wednesday 13 April I organised a seminar and realtime webinar at my firm about M&A in the medical devices sector, to discuss the legal and regulatory implications of an M&A project…
,
Erik Vollebregt
I know, nobody likes reminders. But this one is for a good cause: our free seminar / webinar about M&A in the medical devices sector this Wednesday 13 April in the afternoon. …
,
Erik Vollebregt
Some time ago I wrote about issues often overlooked in medical devices M&A transactions. Because of the reactions to it I decided to organise a seminar at my law firm’s Amsterdam office…
,
Erik Vollebregt
It is a typical scenario: an M&A project is underway, gains momentum and before you know it the pressure is on. The deal must close in time! And then some regulatory points…
,
Erik Vollebregt
With the US authorities announcing that the pharmaceuticals and medical devices industries are squarely in the bullseye of FCPA enforcement and the UK Anti-Bribery Act‘s entry into force around the corner (April…
,
Erik Vollebregt
Last Friday 12 November 2010 I read the analysis item “Sluggish medical device sector ripe for mergers” on Reuters and a more elaborate version of that article on Yahoo. The articles signal…